European Cancer Summit 2020

Working Together Against Cancer: Breaking Down Barriers & Saving Lives

Every year, the European Cancer Organisation brings together leading oncology specialists, patient advocates, politicians and policy-makers to discuss the main issues impacting cancer policy, for the benefit of citizens, cancer patients and healthcare professionals across Europe. 


Despite our best efforts, it has become clear that this year’s European Cancer Summit will be a Virtual Summit.  Unfortunately, the recent increase in new COVID-19 cases across Europe over the summer and the related travel and social distancing restrictions in place, including in Belgium, mean that our Executive Committee have decided that it will be impossible to proceed with any face-to-face participation at the Summit this year.  The European Cancer Summit 2020 will be held virtually on 18 & 19 November, with an extended Special Rate deadline of 30 September.

 

The programme will remain unchanged and will be live, allowing interaction and networking between the delegates and speakers.

 

We will providing all pre-registered delegates with further information and details of the online platform and features, so if you have not yet pre-registered please do so here to receive further information.

18 November 2020 9:00 - 18:15 CET 19 November 2020 9:00 - 18:15 CET

Virtual Edition

Apply for Registration

This year, the European Cancer Summit is more important than ever. The COVID-19 crisis has impacted health care systems and workforces across the world, not least on the resources normally dedicated to cancer early detection and treatment. Citizens with concerns about cancer have been more reluctant to engage with healthcare professionals for fear of catching the virus. Cancer workforces and facilities have been redeployed to deal with the crisis, not always with the right level of protection and support.

And at the same time, two important European cancer initiatives have been under development. Europe’s Beating Cancer Plan, launched on 4 February at the EU Parliament, and the EU Cancer Mission have both been consulting on their plans and looking for medical expertise and patient experience.

So this year, the stage is set for very interesting discussions on a number of topics, prioritised by our member societies as the most important areas of collaboration across disciplines and professions within the @EuropeanCancer family. 

The webcasts from our 2019 European Cancer Summit are available here and the Report is available here.

High-Level Speakers

We will have leading speakers and panellists confirmed and you can see the full gallery of who will be joining us "on stage" here.

Sessions with Relevance & Impact

Our Summit will include sessions on the EU Cancer Mission, Europe’s Beating Cancer Plan; the Impact of COVID-19 on Cancer; as well as the subjects covered by our Focused Topic Networks. Find out the latest information on the programme we are developing here.

Format and Pre-Registration

Despite our best efforts, it has become clear that this year’s European Cancer Summit on 18-19 November 2020 will be a Virtual Summit.  Unfortunately, the recent increase in new COVID-19 cases across Europe over the summer and the related travel and social distancing restrictions in place, including in Belgium, mean that our Executive Committee have decided that it will be impossible to proceed with any face-to-face participation at the Summit this year. 

We are disappointed that we will not be welcoming delegates in person in Brussels, but still delighted with already having over 400 pre-registered delegates for the Summit, including a great group of leading speakers confirmed you can view here and a comprehensive programme available here.

The programme will remain unchanged and will be live, allowing interaction and networking between the delegates and speakers.

We invite everyone interested in attending the European Cancer Summit 2020 to pre-register at the Special Rate by 30 September here. We will providing all pre-registered delegates with further information and details of the online platform and features, so if you have not yet pre-registered please do so here to receive further information.

Registration fees will increase for delegates who pre-register from 1 October onwards.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights

We have leading speakers already confirmed, including: 

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe Read Bio
  • Nicolas Schmit European Commissioner for Jobs and Social Rights Read Bio
  • Walter Ricciardi Chair of the EU Cancer Mission Read Bio
  • Veronique Trillet-Lenoir MEP Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Manfred Weber MEP Chairman, EPP Group in the European Parliament
  • Dolors Montserrat MEP Member, EU Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group and Former Spanish Health Minister Read Bio
  • Petra De Sutter MEP Member, EU Special Committee on Beating Cancer and Chair, Committee on the Internal Market and Consumer Protection and Vice-Chair, MEPs Against Cancer Read Bio
  • Sara Cerdas MEP Shadow Rapporteur, EU4Health; Member, Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group
  • Janina Ochojska MEP Member of the European Parliament, EPP Group-Poland
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs, Group of the European People's Party (Christian Democrats) Read Bio
  • Nicolás González MEP Member of the Special Committee on Beating Cancer Read Bio
  • Andrea Ammon Director, European Centre for Disease Prevention and Control
  • Christine Chomienne Vice Chair of the EU Cancer Mission Read Bio
  • Bettina Ryll EU Cancer Mission Board Member and Founder, Melanoma Patient Network Europe
  • Lori Pierce President, American Society of Clinical Oncology
  • John F Ryan Director, Public Health, Country Knowledge and Crisis Management, DG SANTE Read Bio
  • Regina Beets-Tan EU Cancer Mission Board Member, Member of the European Cancer Organisation Executive Committee, Digital Health Network Co-Chair
  • Thierry Philip EU Cancer Mission Assembly Member and President, Organisation of European Cancer Institutes Read Bio
  • Franco Cavalli Chair, World Oncology Forum and President, Foundation for the Institute of Oncology Research
  • Partha Basu Head, Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, World Health Organization Read Bio
  • Tit Albreht Coordinator, Joint Action innovative Partnership for Action Against Cancer
  • Anja Mehnert Head of Psychosocial Oncology, Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig Read Bio
  • Richard Sullivan Editor-in-Chief, Journal of Cancer Policy, and Director, Institute of Cancer Policy, King's College London
  • Masum Hossain President, International Developed Markets, Pfizer
  • Tristan Almada Co-Founder, HPV and Anal Cancer Foundation and the NOMAN is an Island: Race to End HPV Campaign Read Bio
  • Alexander Zehnder Global Head of Oncology, Sanofi
  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member Read Bio
  • Isabel Rubio Co-Chair of the European Cancer Summit 2020, Board Member of the European Cancer Organisation, Prevention Network Co-Chair Read Bio
  • Stefan Gijjsels Co-Chair of the European Cancer Summit 2020 and Co-Chair of the European Cancer Organisation's Patient Advisory Committee Read Bio
  • Sema Erdem Co-Chair, European Cancer Organisation's Patient Advisory Committee Read Bio
  • Philip Poortmans Past-President, European Cancer Organisation and Quality Cancer Care Network Co-Chair Read Bio
  • Wim Oyen Treasurer, European Cancer Organisation and Digital Health Network Co-Chair Read Bio
  • Dominique de Valeriola Member, European Cancer Organisation Executive Committee
  • Denis Lacombe European Cancer Organisation Health Systems and Treatment Optimisation Network Co-Chair
  • Yolande Lievens European Cancer Organisation Health Systems and Treatment Optimisation Network Co-Chair
  • Caroline Dive President, European Association for Cancer Research
  • Margaret Stanley President, International Papillomavirus Society
  • Catherine Owen Senior Vice President, Major Markets, Bristol-Myers Squibb Read Bio
  • Nicoletta Luppi Senior Vice President and Managing Director, MSD Italia Read Bio
  • Simon Oberst European Cancer Organisation Quality Cancer Care Network Co-Chair
  • Mirjam Crul Board Member, European Cancer Organisation, Special Network on the Impact of COVID-19 on Cancer Co-Chair and Workforce Network Co-Chair Read Bio
  • Mark Lawler Board Member, European Cancer Organisation and Special Network on the Impact of COVID-19 on Cancer Co-Chair Read Bio
  • Nathalie Moll Director General, European Federation of Pharmaceutical Industries
  • Andreas Charalambous European Cancer Organisation Workforce Network Co-Chair
  • Padraic Ward Head of Commercial Operations, Roche Read Bio
  • Kathy Oliver Vice-Chair, European Cancer Organisation's Patient Advisory Committee
  • Peter Lührs Therapeutic Area Head Oncology, Bayer Read Bio
  • Daniel Kelly European Cancer Organisation HPV Action Network Co-Chair
  • Rui Medeiros European Cancer Organisation HPV Action Network Co-Chair
  • Hein Van Poppel European Cancer Organisation Inequalities Network Co-Chair
  • Nicolò Battisti European Cancer Organisation Inequalities Network Co-Chair
  • Andrew Davies European Cancer Organisation Survivorship and Quality of Life Network Co-Chair
  • Csaba Dégi Board Member, European Cancer Organisation and Survivorship and Quality of Life Network Co-Chair Read Bio
  • Robert Greene Member, European Cancer Organisation's Patient Advisory Committee Read Bio
  • Šarūnas Narbutas Chairman, Youth Cancer Europe
  • Jan Van Meerbeeck Board Member, European Cancer Organisation and Prevention Network Co-Chair Read Bio
  • Jan Geissler EU Cancer Mission Assembly Member and Member of the European Cancer Organisation's Patient Advisory Committee Read Bio
  • Françoise Meunier Vice President, Federation of European Academies of Medicine Read Bio
  • Cobi Reisman Past-President, European Society of Sexual Medicine
  • Harry de Koning Deputy Head, Public Health and Screening Evaluation, Department of Public Health, Erasmus MC Read Bio
  • Gilliosa Spurrier Member, European Cancer Organisation's Patient Advisory Committee, Chair, WECAN and Member, Melanoma Patient Network Europe Read Bio
  • Fred Prior Professor and Chair, Department of Biomedical Informatics, Professor of Radiology, University of Arkansas for Medical Sciences
  • Alexandru Eniu Deputy Scientific Director, European School of Oncology and Senior Medical Oncologist, Breast Cancer Tumor Lead, Hopital Riviera-Chablais
  • Emilie Karafillakis European Research Lead, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine Read Bio
  • Kathi Apostolidis President, European Cancer Patient Coalition
  • Katie Reeder-Hayes Chair, Health Equity Committee, American Society of Clinical Oncology
  • Wiro Niessen Principal Investigator, Radiology & Nuclear Medicine, Erasmus MC
  • Lynda Wyld Professor, Surgical Oncology, Department of Oncology and Metabolism, The University of Sheffield Read Bio
  • Lydie Meheus Managing Director, Anticancer Fund Read Bio
  • Bengt Jönsson Professor Emeritus of Health Economics, Stockholm School of Economics, Sweden Read Bio
  • Benjamin Besse Professor of Medical Oncology, Paris-Saclay University, France Read Bio

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights

Despite our best efforts, it has become clear that this year’s European Cancer Summit on 18-19 November 2020 will be a Virtual Summit.  Unfortunately, the recent increase in new COVID-19 cases across Europe over the summer and the related travel and social distancing restrictions in place, including in Belgium, mean that our Executive Committee have decided that it will be impossible to proceed with any face-to-face participation at the Summit this year. 

The programme will remain unchanged and will be live, allowing interaction and networking between the delegates and speakers.

We invite everyone interested in attending the virtual European Cancer Summit 2020 to pre-register at the Special Rate by 30 September.  We will providing all pre-registered delegates with further information and details of the online platform and features, so if you have not yet pre-registered please do so below to receive further information.

Registration fees will increase for delegates who pre-register from 1 October onwards.  Cancelled registrations are not refundable from 17 September 2020, but can be eligible for a change of name for €175.  Please contact us if you have any questions.

  • Select your profile

    Please note that this information will be verified
    Special rate Virtual
    Standard rate Virtual
  • 150
  • 350
  • 500
  • 700
  • 500

Complete the information below

I agree that my data will be used for registration purposes and to create a participant list that will be circulated at the event
I also want to subscribe to the European Cancer Organisation's newsletter
Upload the proof of membership

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights

Working Together Against Cancer: Breaking Down Barriers & Saving Lives

The co-chairs of the European Cancer Summit 2020, Isabel Rubio and Stefan Gijssels, are working with the co-chairs of our Focused Topic Networks to finalise a relevant and impactful programme with leading speakers. We will update this page regularly with detailed information about each session.



Wednesday 18 November 2020

(Timelines subject to change)

09:00-09:15  Opening Session

President of the European Cancer Organisation, Dr Matti Aapro and Summit Co-Chairs, Isabel Rubio and Stefan Gijssels open the Summit with their introductions for the coming sessions.

09:15-10:45 Impact of COVID-19 on Cancer

No area of cancer care has been left undamaged by the impacts of COVID-19. Harm has been inflicted on prevention efforts, such as vaccination, through to screening, treatment and follow up care. While rapid catchup is required, so too is frank debate and resolution about what lessons must be learnt and applied most quickly to place Europe on a stronger footing for the likely 'next time'. We invite Europe's cancer community to join us for this critical exchange.

10:45-11:00 Coffee Break

11:00-12:30 Health Systems and Treatment Optimisation 

How can health systems bring meaningful innovations in cancer care into practice in a manner that is cost proportionate and rational? How can more be made out of the tools, treatments and services already available for cancer care?

In response to such questions, the European cancer community has identified the need for new approaches. Such proposals include greater application of value-based healthcare, better use of outcome measures, and the application of policies that will improve treatment optimisation. Our Health Systems and Treatment Optimisation Network promotes fresh consensus on these topics and collaboration to achieve earlier realignment of health systems in these directions.

This Summit session will provide opportunity for leading thinkers in this space to share views and debate proposals with a wider audience.

12:30-13:00 Lunch

13:00-14:15 Quality Cancer Care

2020 is an eventful year for the Quality Cancer Care agenda in Europe. The run-up to the European Cancer Summit marks the publication of a new European Code of Cancer Practice, new Essential Requirements for Quality Cancer Care for Breast Cancer, Prostate Cancer and Lung Cancer, and the launch of our new Quality Cancer Care Network at the European level. The Organisation of European Cancer Institutes has also published 100 European core quality standards for cancer care and research centres and the European Cancer Organisation is now in the process of developing Essential Requirements for Quality Cancer Care for Pancreatic Cancer, Ovarian Cancer and Glioma. The European Cancer Summit will give the opportunity to not only reflect on these key developments but also to plan ahead together for an even more impactful 2021. Quality Cancer Care is everyone's concern. We invite you to bring your perspective and make your voice heard.

14:15-15:30 Inequalities: Disparities and Discrimination in Cancer Care

Our Inequalities Network aims to identify and highlight the existing disparities in access and delivery of evidence-based care and optimal outcomes for patients with cancer across Europe. Inequalities may discriminate against patients with cancer based on nationality, geography, ethnicity, gender, sexual orientation, age, literacy, income, availability of clinical trials and presence of disability. Inequalities are a major source of variation in cancer care for various groups of patients and should be a key topic for policy makers.

This session will provide insight into ongoing initiatives to tackle disparities in cancer care and future directions to ensure equity in cancer care across Europe.

Moderated by the Co-Chairs of our Inequalities Network, Nicolo Battisti and Hein Van Poppel, we are delighted to have a panel of speakers that will speak on different aspects of the Inequalities issue:

  • Dr. Lori J. Pierce, President of the American Society of Clinical Oncology
  • Richard Sullivan, Editor-in-Chief, Journal of Cancer Policy, and Director, Institute of Cancer Policy, King's College London
  • Petra de Sutter, MEP, Member, EU Special Committee on Beating Cancer and Chair, Committee on the Internal Market and Consumer Protection
  • Robert Greene, Member of the European Cancer Organisation's Patient Advisory Committee
  • Masum Hossain, President, International Developed Markets, Pfizer
  • Katie Reeder-Hayes, Chair, Health Equity Committee, American Society of Clinical Oncology

15:30-15:45 Coffee Break

15:45-17:00 Prevention

COVID-19 served to remind all of us that prevention really is significantly preferable to cure. With that painfully re-learnt lesson in mind, where can Europe go next on cancer prevention? What can Europe's Beating Cancer Plan and the EU Cancer Mission do on such matters as improving tobacco control and diet and addressing research gaps? 17 years after the landmark EU Council Conclusions on cancer screening what more can be done to take on board the science, evidence and practice on screening that has accrued in the intervening years?

Our Prevention Network addresses itself to these matters. The session will articulate viewpoints and activity from the Network as well as indicating Network actions in 2021.


17:00-18:00 Europe’s Beating Cancer Plan

Stella Kyriakides, EU Commissioner for Health and Food Safety will join the @EuropeanCancer community to share the latest progress on Europe’s Beating Cancer Plan, due to be finalised before the end of 2020.  This follows months of consultation after the launch of the Plan at the EU Parliament on World Cancer Day, 4 February 2020.  The plan should provide actions to accelerate and improve country coordination in combatting cancer. The European Cancer Summit 2020 is ideally timed to hear the latest information about the plan and to discuss together its implementation in 2021.  The Commissioner will be joined “on stage” by the European Cancer Organisation’s Executive Committee, as well as the co-chairs of this year’s Summit, for questions and discussion.

 

Thursday 19 November 2020

(Timelines subject to change)

09:00-10:30 Mission-Driven Cancer Research: All Together as One

The European Cancer Summit will shine a spotlight on the concluding work of the European Cancer Mission Board, ahead of the formal commencement of the EU Cancer Mission in 2021.

The session will open with a keynote address from Mariya Gabriel, EU Commissioner for Innovation, Research, Culture, Education and Youth, in which the overall approach of the European Commission 2019-24 towards cancer research will be outlined.

Thereafter, moderated by Dr Matti Aapro, President of the European Cancer Organisation and Member of the Cancer Mission Assembly, panelists will explore key targets and actions of the forthcoming Mission, including its focus on areas such as Prevention, Quality of Life and Survivorship and other major challenges to be tackled within its programme of action.

Panelists include:

  • Walter Ricciardi, Chair of the EU Cancer Mission Board
  • Christine Chomienne, Vice-Chair of the EU Cancer Mission Board
  • Bettina Ryll, Member of the EU Cancer Mission Board and Founder of the Melanoma Patient Network Europe
  • Caroline Dive, President of the European Association for Cancer Research
  • Nathalie Moll, Director General at European Federation of Pharmaceutical Industries


10:30-10:45 Coffee Break

10:45-12:00 Survivorship and Quality of Life

The inclusion of a specific section of Europe's Beating Cancer Plan dedicated to Survivorship and Quality of Life issues represented a landmark in confirming the high political recognition this agenda has now achieved. Supporting this, our Survivorship and Quality of Life Network is devoted to pushing policy-makers to go further faster in tackling issues such as discrimination against cancer patients and survivors, providing better quality supportive care and to beating cancer stigma and fear.

This session will elaborate on key recent developments and hear testimony to inspire all of us to push harder for cancer care that truly looks after the whole patient, not only the disease.

12:00-12:45 Lunch 

12:45-14:00 Preparing a Resilient Oncology Workforce for the Present and Future

Without a workforce you have no cancer care. Continual policy attention must be provided to such matters as education and training, labour mobility, professional qualification recognition and addressing workforce shortages. Europe has a role in all these areas. Yet it appears far from clear that, to date, this role has met its full potential.

Our Workforce Network will guide attendees through the most current issues, their resonance to cancer care, and provide illustration of the paths to improvement.

14:00-15:15 Viral Protection: Achieving the Possible. The elimination of HPV cancers in Europe

2020 will be the year when the global community commits itself to the elimination of a cancer caused almost entirely by HPV through the World Health Organisation’s new cervical cancer strategy. What will be Europe's role in this global effort and can it go further and achieve the elimination of all the cancers caused by HPV?

The speakers in this session of the Summit will address this issue head-on.

Dr Andrea Ammon, Director General of the European Centre for Disease Prevention and Control (ECDC), will make a keynote address: ‘Time for Action: Overcoming the barriers to HPV cancer elimination’

There will also be presentations on:

An HPV cancer free Europe by 2030: Is it really possible?
  • Prof Margaret Stanley, President, International Papillomavirus Society (IPVS)
Advocating for HPV cancer elimination: the role of civil society organisations
  • Tristan Almada, Co-Founder, HPV and Anal Cancer Foundation and the Noman Is An Island: Race to End HPV Campaign
  • Dr Cobi Reisman, Past President, European Society for Sexual Medicine (ESSM)
Meeting the challenge of ‘fake news’ head on
  • Emilie Karafillakis, European Research Lead, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine

The session will be moderated by the Co-Chairs of the HPV Action Network, Prof Daniel Kelly and Prof Rui Medeiros. The Network is a multi-disciplinary collaboration between organisations and individuals that focuses on the key issues of HPV vaccination, screening, treatment, and education/awareness by both the public and healthcare professionals.

15:15-15:30 Coffee Break

15:30-17:00 The Digital Transformation of Cancer Care

10, 20 and 30 years from now, how will technology have changed cancer care? What preparations for those futures should we already be making? What technologies already at our fingertips are we failing to make best use of?

Led by our Digital Health Network, this session will hear experience from leading experts, share perspectives from a range of stakeholders on key controversies and open new horizons for attendees about the coming possibilities.


17:00-18:00 Cancer Issues Worldwide

We are honoured that HRH Princess Dina Mired, President of the Union for International Cancer Control, will join Dr Matti Aapro, President of the European Cancer Organisation, for a debate with oncology leaders about issues impacting cancer around the world. Also among Dr Aapro’s guests will be Prof Franco Cavalli, Chair of the World Oncology Forum and Catherine Owen, Senior Vice President, Major Markets, Bristol-Myers Squibb (with additional guests to be confirmed).

18:00-18:15 Closing Session

President of the European Cancer Organisation, Dr Matti Aapro and Summit Co-Chairs, Isabel Rubio and Stefan Gijssels close the Summit with their observations from the previous sessions.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired President, Union for International Cancer Control, Jordan
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe
  • Nicolas Schmit European Commissioner for Jobs and Social Rights